Abstract
Interferons (IFNs) are a family of secreted proteins with antiviral, antiproliferative and immunomodulatory activities. On the basis of their antigenic properties, they are classified as three major groups α, β, and γ. IFNs α and β(type I) are produced by many cell types upon viral infection, double stranded RNA treatment, or other stimuli, whereas IFN γ (type II) is induced in T lymphocytes or natural killer cells in response to antigens or mitogens (Chelbi-Alix et al., 1994; Chelbi-Alix and Chousterman, 1992; Pestka et al., 1987; Sen and Ransohoff, 1993). After interacting with their cognate cell surface receptors, IFNs α/β and IFN γ activate different signal transduction cascades leading to the transcription of distinct sets of genes which mediate the biological effects of these cytokines. The IFN α/β- and the IFN γ-inducible gene promoters are characterized by the presence of consensus elements the interferon-stimulated response element (ISRE) and the gamma activated sequence (GAS) respectively. Binding of both IFN α/β and IFN γ results in the differential activation of latent cytoplasmic transcription factors termed STATS (Signal Transducer and Activator of Transcription) that act at different cis-acting DNA elements. Tyk2 and JAK1 kinases play a central roles in the induction of IFN α/β; responsive genes and JAK1 and JAK2 in that of IFN γ (Pelligrini and Schindler, 1993)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alcalay, M., Zangrilli, D., Fagioli, M., Pandolfi, P.P., Mencarelli, A., Lo Coco, F., Biondi, A., Grignani, F. and Pelicci, P.G. (1992) Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia. Proc Natl Acad Sci U S A 89: 4840–4844.
Barlow, P.N., Luisi, B., Milner, A., Elliott, M. and Everett, R. (1994) Structure of the C3HC4 domain by 1H-nuclear magnetic resonance spectroscopy. A new structural class of zinc- finger. J. Mol. Biol. 237: 201–211.
Bollag, W. (1991) Retinoid and interferon: a new promising combination Brit. Hematol. 79: 87–91.
Chelbi-Alix, M.K., Brouard, A., Boissard, C., Pelaprat, D., Rostene, W. and Thang, M.N. (1994) Induction by Vasoactive Intestinal peptide of interferon synthesis in glial cells but not in neurons J. Cell. Physiol. 158: 47–54.
Chelbi-Alix, M.K. and Chousterman, S. (1992) Ethanol induces 2′5′ oligoadenylate synthetase and antiviral activities through interferon β production J. Biol. Chem. 267: 1741–1745
Chelbi-Alix, M.K., Pelicano, L., Quignon, F., Koken, M.H.M., Venturini, L., Stadler, M., Pavlovic, J., Degos, L. and de Thé, H. (1995) Induction of PML protein by interferons in normal and APL cells. Leukemia, in press.
Daniel, M., Koken, M., Romagné, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, Degos, L., Chommienne, C., and de Thé, H. (1993) PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82: 1858–1867.
de Thé, H., Chomienne, C., Lanotte, M., Degos, L. and Dejean, A. (1990) The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature 347: 558–561.
de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L. and Dejean, A. (1991) ThePML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell. 66: 675–84.
Dyck, J.A., Maul, G.G., Miller, W.H., Chen, J.D., Kakizuka, A. and Evans, R.M. (1994) A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein Cell 76: 333–343.
Fagioli, M., Alcalay, M., Pandolfi, P.P., Venturini, L., Mencarelli, A., Simeone, A., Acampora, D., Grignani, F. and Pelicci, P.G. (1992) Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 7: 1083–1091.
Freemont, P.S. (1993) The RING finger. A novel protein sequence motif related to the zinc finger.Annals N Y Acad. Sci. 684: 174–192.
Gallagher, R.E., Lurie, K.J., Leavitt, R.D. and Wiernik, P.H. (1987) Effects of interferon and retinoic acid on the growth and differentiation of clonogenic leukemic cells from acute myelogenous leukemia patients treated with recombinant leukocyte-αA interferon. Leukemia Res. 11: 609–619.
Goddard, A.D., Borrow, J. and Solomon, E. (1992) A previously uncharacterized gene, PML, is fused to the retinoic acid receptor alpha gene in acute promyelocytic leukaemia. Leukemia 6: 117S–119S.
Guldner, H., Szostecki, C., Grotzinger, T. and Will, H. (1992) IFN enhances expression of Sp100, an autoantigen in primary biliary cirrhosis J. Immunol. 149: 4067–4073.
Gutterman, J. (1994) Cytokine therapeutics: lessons from interferon α.Proc. Natl. Acad. Sci. USA 91: 1198–1205.
Hovanessian, A.G. (1993) Interferon-induced dsRNA-activated protein kinase (PKR): antiproliferative antiviral and antitumoral functions. Virology 4: 237–245.
Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M.P., Durand, B., Lanotte, M., Berger, R. and Chambon, P. (1992) Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins EMBO J. 11: 629–642.
Koken, M.H.M., Linares-Cruz, G., Quignon, F., Viron, A., Chelbi-Alix, M.K., Sobczak-Thépot, J., Juhlin, L., Degos, L., Calvo, F. and de Thé, H. (1995) The PML growth-suppressor has an altered expression in human Oncogenesis 10: 1315–1324.
Koken, M.H.M., Puvion-Dutilleul, F., Guillemin, M.C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., Chomienne, C., Degos, L., Puvion, E. and de Thé, H. (1994) The t(15;17) translocation alters a nuclear body in a RA-reversible fashion. EMBO J. 13: 1073–1083.
Korioth, F., Gieffers, C., Maul, G.G. and Frey, J. (1995) Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J. Cell Biol. 130: 1–13.
Koromilas, A.E., Roy, S., Barber, G., Katze, M.G. and Sonenberg, N. (1992) Malignant transformation by a mutant of the IFN-inducible dsRNA-protein kinase. Science 257: 1685–1689.
Lanotte, M., Martin-Thouvenin, V., Najman, S., Balerini, P., Vaiensi, F. and Berger, R.(1991) NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia. Blood. 77: 1080–1086.
Lippman, S.M., Kavanagh, J.J., Paredes-Espinosa, M., Delgadillo-Madrueno, F., Paredes- Casillas, P., Hong, W.K., Holdener, E. and Krakoff, I.H. (1992) 13-cis-Retinoic acid plus Interferon α-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J. Natl. Cancer Inst. 84: 241–245.
Lippman, S.M., Parkinson, D.R., Itri, L.M., Weber, R.S., Schantz, S.P., Ota, D.M., Schusterman, M.A., Krakoff, I.H., Gutterman, J.U. and Hong, W.K. (1992b)., 13-cis-Retinoic Acid and Interferon α- 2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J. Natl. Cancer Inst 84: 235–241.
Liu, J.-H., Mu, Z.-M. and Chang, K.-S. (1995) PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu.. J. Exp. Med. 181: 1965–1973.
Mahé, D., Roussev, R., Lutz, Y., Puvion-Dutilleul, F. and Fuchs, J.P. (1995) Two hnRNP-associated proteins share common structural features with the adenoviral 72-kDA protein. Exp. Cell Res. 216: 1–12.
Maul, G.G. and Everett, R.D. (1994) The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J. Gen. Virol. 75: 1223–1233.
Maul, G.G., Guldner, H.H. and Spivack, J.G. (1993) Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICPO). J. Gen. Virol. 74: 2679–2690.
Meurs, E., Hovanessian, A.G., Montagnier, L. (1981) Interferon-mediated antiviral state in human MRC5 cells in the absence of detectable levels of 2–5 A synthetase andprotein kinase. J. Interferon Res. 1: 219–232.
Meurs, E., Galabru, J., Barber, G., Katze, M.G. and Hovanessian, A.G. (1993) Tumorsuppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 90: 232–236.
Miki, T., Fleming, T., Crescenzi, M., Molloy, C., Blam, S., Reynolds, S. and Aaronson, S. (1991) Development of a highly efficient expression cDNA cloning system: application to oncogene isolation. Proc. Natl. Acad. Sci. USA 88: 5167–5171.
Mu, Z.M., Chin, K.V., Liu, J.H., Lozano, G. and Chang, K.S. (1994) PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14: 6858–6867.
Pellegrini, S. and Schindler, C. (1993) Early events in signalling by interferons. TIBS 18: 338–342.
Perez, A., Kastner, P., Sethi, S., Lutz, Y., Reibel, C. and Chambon, P. (1993) PML/RAR homodimers: distinct binding properties and heteromeric interactions with RXR. EMBO J. 12:3171–3182.
Pestka, S., Langer, J.A., Zoon, K.C. and Samuel, C.E. (1987) Interferons and their actions. Ann.Rev.Biochem 56: 727–777.
Puvion-Dutilleul, F., Chelbi-Alix, M.K., Koken, M., Quignon, F., Puvion, E. and de Thé, H. (1995) Adenovirus infection induces rearrangements in the intranuclear distribution of the nuclear body -associated PML protein. Exp. Cell Res. 218: 9–16.
Reddy, B., Etkin, L. and Freemont, P. (1992) A novel zinc finger coiled-coil domain in a family of nuclear proteins. TIBS 17: 344–345.
Schindler, C. and Darnell Jr., J.E. (1995) Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Ann. Rev. Biochem. 64: 621–651.
Sen, G.C. and Ransohoff, R.M. (1993) Interferon-induced antiviral actions and their regulation Advances in Virus Research 42: 57–102.
Stadler, M., Chelbi-Alix, M.K., Koken, M.H. M., Venturini, L., Lee, C., Saïb, A., Quignon, F., Pelicano, L., Guillemin, M.-C., Schindler, C. and de Thé, H. (1995) Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene in press.
Staeheli, P. (1990) Interferon-induced proteins and the antiviral state. Advances in virus research 38: 147–201.
Staeheli, P., Pitossi, F. and Pavlovic, J. (1993) Mx proteins: GTPases with antiviral activity Trends in Cell. Biol. 3: 268–272..
Szostecki, C., Krippner, H., Penner, E. and Bautz, F. (1987) Autoimmune sera recognize a 100 kD nuclear protein antigen. Clin. Exp. Immunol. 68: 108–115.
Testa, U., Grignani, F., Barberi, T., Fagioli, M., Masciulli, R., Ferrucci, P.F., Seripa, D., Camagna, A., Alcalay, M., Pellici, P.G. and Peschle, C. (1994) PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3. Cancer Res. 54: 4508–4515.
Tissot, C., and Mechti, N. (1995) Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type long terminal repeat expression. J. Biol. Chem 270: 14891–14898.
Visa, N., Puvion-Dutilleul, F., Harper, F., Bachellerie, J.P. and Puvion, E. (1993) Intranuclear distribution of poly A RNA determined by electron microscopy in situ hybridization. Exp.Cell Res. 208: 19–34.
Warrell, R., de Thé, H., Wang, Z. and Degos, L. (1993) Acute promyelocyte leukemia. New Engl. J. Med. 329: 177–189.
Warrell, R.P. (1993) Retinoid resistance. The Lancet 341: 126.
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A. and Dejean, A. (1994) Retinoic acid regulates aberrant nuclear localization of PML/RARα in acute promyelocyte leukemia cells. Cell. 76: 345–356.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Chelbi-Alix, M.K., Pelicano, L., Quignon, F., Koken, M., de Thé, H. (1996). PML Is a Primary Target Gene of Interferon and Could Mediate Some of Its Biological Activities. In: Tsiftsoglou, A.S., Sartorelli, A.C., Housman, D.E., Dexter, T.M. (eds) Tumor Biology. NATO ASI Series, vol 99. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61180-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-61180-3_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64735-2
Online ISBN: 978-3-642-61180-3
eBook Packages: Springer Book Archive